CeloNova BioSciences, Inc. today announced that it will showcase the technology behind the CATANIA(TM) Coronary Stent System featuring a NanoThin Polyzene(R)-F surface treatment during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium sponsored by the Cardiovascular Research Foundation October 12-17. The CATANIA(TM) Coronary Stent System carries a CE Mark and is currently available for sale outside the United States.
FULL STORY

Source: Medical Devices / Diagnostics News From Medical News Today